Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous subthreshold retinal photocoagulation plus anti-VEGF vs anti-VEGF monotherapy for diabetic macular edema
jRCTs031180182Completed
- Sponsor
- Bayer
- Start
- Oct 2016
- Countries
- 1
01
Overview
Randomised trial in diabetic macular edema (DME) (2 arms), sponsored by Bayer. Primary endpoint: Time to reinjection after initial 3 monthly anti-VEGF injections. Started Oct 2016; status: completed.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCTs031180182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180182.